SENSEONICS HOLDINGS INC (SENS) competitors & alternatives
Health Care · NASDAQ
SENSEONICS HOLDINGS INC (SENS)'s top competitors and alternatives — its most similar public companies — include Dexcom (DXCM), Medtronic (MDT), MINIMED INC (MMED), Insulet Corporation (PODD), MANNKIND CORP (MNKD), LEXICON PHARMACEUTICALS INC (LXRX), CVRX INC (CVRX), EMBECTA CORP (EMBC), TANDEM DIABETES CARE INC (TNDM), BETA BIONICS INC (BBNX), ADAPTHEALTH CORP (AHCO) and Lilly (Eli) (LLY). These are SENSEONICS HOLDINGS INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top SENS competitors & alternatives
-
DexcomDXCMHealth Care
Dexcom is a leader in continuous glucose monitoring (CGM) technology, providing essential real-time health data for diabetes management and metabolic health.
$71.43 (as of 2026-07-22) · market cap $28.8B
-
MedtronicMDTHealth Care
Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain,…
$81.89 (as of 2026-07-22) · market cap $105.1B
-
MINIMED INCMMEDHealth Care
MiniMed is a diabetes care technology company specializing in automated insulin delivery pumps, continuous glucose monitors, and smart insulin pens for global…
$16.33 (as of 2026-07-22) · market cap $4.6B
-
Insulet CorporationPODDHealth Care
Insulet Corporation provides tubeless, wearable insulin management technology that simplifies diabetes care for millions of patients worldwide.
$158.93 (as of 2026-07-22) · market cap $11.3B
-
MANNKIND CORPMNKDHealth Care
MannKind is a biopharmaceutical company specializing in drug-device combinations, including inhaled therapies and on-body infusors, to treat cardiometabolic…
$3.84 (as of 2026-07-22) · market cap $1.2B
-
LEXICON PHARMACEUTICALS INCLXRXHealth Care
An early-stage commercial biopharmaceutical company with a gene-discovery platform advancing cardiovascular and metabolic therapies, headlined by…
$2.25 (as of 2026-07-22) · market cap $1.0B
-
CVRX INCCVRXHealth Care
CVRx commercializes Barostim, the first FDA-approved neuromodulation device that activates baroreceptors to treat severe heart failure in patients who fail…
$5.09 (as of 2026-07-22) · market cap $135M
-
EMBECTA CORPEMBCHealth Care
A dedicated diabetes care company specializing in insulin delivery systems and pen needles for millions of users worldwide.
$3.25 (as of 2026-07-22) · market cap $193M
-
TANDEM DIABETES CARE INCTNDMHealth Care
Tandem designs intelligent, consumer-friendly insulin pumps with automated closed-loop technology to help people with insulin-dependent diabetes manage their…
$16.91 (as of 2026-07-22) · market cap $1.2B
-
BETA BIONICS INCBBNXHealth Care
Beta Bionics is a medical device company developing automated insulin delivery systems to simplify diabetes management.
$16.31 (as of 2026-07-22) · market cap $780M
-
ADAPTHEALTH CORPAHCOHealth Care
AdaptHealth delivers home medical equipment, supplies, and chronic disease management services directly to patients, focusing on sleep apnea, respiratory…
$10.88 (as of 2026-07-22) · market cap $1.5B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,163.01 (as of 2026-07-22) · market cap $1.09T
Not quite? Describe exactly what you want →
Peers are SENSEONICS HOLDINGS INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: SENSEONICS HOLDINGS INC (SENS).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.